Citi raised the firm’s price target on Ardelyx to $14 from $13 and keeps a Buy rating on the shares post the Q1 report. Xphozah’s’s first full quarter of launch handily beat expectations, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARDX:
- Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
- Ardelyx price target lowered to $13 from $14 at Citi
- Ardelyx call volume above normal and directionally bullish
- Krispy Kreme upgraded, Altice USA downgraded: Wall Street’s top analyst calls
- Ardelyx initiated with an Outperform at Leerink